This site uses cookies to store information on your computer. Learn more x

DSM appoints new Executive Vice President Corporate Strategy & Acquisitions

Heerlen, NL, 23 Aug 2011 10:15 CEST

Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following:

Philip Eykerman, (1968), currently Partner at McKinsey & Company, Brussels office, will join DSM as Executive Vice President Corporate Strategy & Acquisitions, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board of DSM.

Philip will succeed Hein Schreuder, currently EVP Corporate Strategy & Acquisitions, who after a very successful career of 20 years at DSM, will retire from the company on December 31, 2011. Hein has played a key role in the transformation of DSM as well as in the acquisitions and divestments of the company during the last 15 years.

Philip, a Belgian national, joined McKinsey & Company in 1997 and is the leader of McKinsey's Chemicals Practice in the Benelux and France. He has been heavily involved in a number of significant strategy development, transformation and M & A projects in the broader chemicals industry.

With his track record of strategy development and M & A strategy and integration, Philip is well positioned to lead DSM's corporate strategy and acquisition department and drive the development of DSM's strategic growth agenda.